Literature DB >> 17306997

Severe pseudo-preseptal cellulitis following sub-Tenon's carboplatin injection for intraocular retinoblastoma.

Hayyam Kiratli1, Sibel Kocabeyoğlu, Sevgül Bilgiç.   

Abstract

Sub-Tenon or subconjunctival administration of carboplatin is used to consolidate tumor regression by achieving high intraocular concentrations, without incurring systemic toxicity, in selected patients with intraocular retinoblastoma. Mild transient periocular edema is a common side effect of this treatment. We describe four patients with severe local soft-tissue toxic reaction mimicking preseptal cellulitis following subtenon carboplatin injections. The development of this complication after injecting through the inferior conjunctiva and unexpectedly severe signs are the unusual features of these patients. We did not encounter this complication after injections through the superior conjunctiva in 22 other patients using the same technique and identical drug dosage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306997     DOI: 10.1016/j.jaapos.2006.11.005

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  10 in total

Review 1.  Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma.

Authors:  Uma M Sachdeva; Joan M O'Brien
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

Review 2.  Current update on retinoblastoma.

Authors:  Samuel K Houston; Timothy G Murray; Stacey Quintero Wolfe; Cristina E Fernandes
Journal:  Int Ophthalmol Clin       Date:  2011

3.  Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma.

Authors:  Lejla Mutapcic Vajzovic; Timothy G Murray; Mohammad A Aziz-Sultan; Amy C Schefler; Stacey Quintero Wolfe; Ditte Hess; Cristina E Fernandes; Sander R Dubovy
Journal:  Clin Ophthalmol       Date:  2011-02-10

4.  Severe aseptic orbital cellulitis with subtenon carboplatin for intraocular retinoblastoma.

Authors:  Parag K Shah; N Kalpana; V Narendran; Minu Ramakrishnan
Journal:  Indian J Ophthalmol       Date:  2011 Jan-Feb       Impact factor: 1.848

5.  Retinoblastoma: Recent trends A mini review based on published literature.

Authors:  Vikas Khetan; Aditi Gupta; Lingam Gopal
Journal:  Oman J Ophthalmol       Date:  2011-09

Review 6.  A Glossary for ''Pseudo'' Conditions in Ophthalmology.

Authors:  Burak Turgut; Sabiha Gungor Kobat
Journal:  Beyoglu Eye J       Date:  2020-12-28

7.  Current therapy and recent advances in the management of retinoblastoma.

Authors:  Rachna Meel; Venkatraman Radhakrishnan; Sameer Bakhshi
Journal:  Indian J Med Paediatr Oncol       Date:  2012-04

Review 8.  Conservative treatment modalities in retinoblastoma.

Authors:  Bhavna Chawla; Amit Jain; Rajvardhan Azad
Journal:  Indian J Ophthalmol       Date:  2013-09       Impact factor: 1.848

9.  Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review.

Authors:  Jasmine H Francis; David H Abramson; Y Pierre Gobin; Brian P Marr; Ira J Dunkel; Elyn R Riedel; Scott E Brodie
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

10.  Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: an animal trial.

Authors:  Debraj Shome; Dhrubajyoti Kalita; Viral Jain; Rajiv Sarin; Girish B Maru; Jayesh R Bellare
Journal:  Indian J Ophthalmol       Date:  2014-05       Impact factor: 1.848

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.